US 9,067,896 · Application 13/514,308 · Granted Jun 30, 2015
US 9,067,896
Crystalline forms of 3-(2,6-dichloro-3,5-dimethoxy-phenyl)-1-{ 6-[4-(4-ethyl-piperazin-1-yl) -phenylamino] -pyrimidin-4-yl}-1-methyl-urea and salts thereof
Estimated expiration
August 6, 2028
1y 323d remaining
- Could not download TD document I3IX20KAPXXIFW3:
Earliest effective filing
Dec 6, 2010
+ 20 years
Dec 6, 2030
PTA +80d
Feb 24, 2031
TD cap (US 8,293,746)
Aug 6, 2028
Final
Aug 6, 2028
This calculation includes patent term adjustment (PTA) under 35 U.S.C. §154(b). Patent term extension (PTE) under 35 U.S.C. §156 (for FDA-regulated products) is not included. Terminal disclaimers can affect PTA (In re Cellect, LLC).
Calculation details
Base term
- Filing date
- June 7, 2012
- Earliest effective filing
- December 6, 2010
- Issue date
- June 30, 2015
- PTA
- +80 days
- Base expiry (before PTA)
- December 6, 2030
December 6, 2010 + 20 years = December 6, 2030 + 80 PTA days = February 24, 2031
- National stage entry of application PCTUS2010059108, filed Dec 6, 2010
- PRO61/267,155 — Provisional — not used for base term
- PRO61/267,155 — Provisional — not used for base term
Terminal disclaimers
TD caps expiration to August 6, 2028 (earliest expiring referenced patent: US 8,293,746)
US 8,293,746· Application 12/158,873Capping patent
Pyrimidinyl aryl urea derivatives being fgf inhibitors
- Filing date
- Jun 23, 2008
- Earliest effective filing
- Dec 20, 2006
- Issue date
- Oct 23, 2012
- PTA
- +595 days
- Calculated expiration
- Aug 6, 2028
National stage entry of PCTEP2006070046, filed Dec 20, 2006
Dec 20, 2006 + 20y + 595d PTA = Aug 6, 2028
US 9,067,896· Application 13/514,308(from application 13/514,308)
Crystalline forms of 3-(2,6-dichloro-3,5-dimethoxy-phenyl)-1-{ 6-[4-(4-ethyl-piperazin-1-yl) -phenylamino] -pyrimidin-4-yl}-1-methyl-urea and salts thereof
- Filing date
- Jun 7, 2012
- Earliest effective filing
- Dec 6, 2010
- Issue date
- Jun 30, 2015
- PTA
- +80 days
- Calculated expiration
- Feb 24, 2031
National stage entry of PCTUS2010059108, filed Dec 6, 2010
Dec 6, 2010 + 20y + 80d PTA = Feb 24, 2031
Patent term extension under 35 U.S.C. §156, which can apply to certain drug, biologic, animal drug and medical device patents, is not included in this calculation. How PTE is calculated
The prosecution record for your AI
Application 13/514,308 · US 9,067,896
You have the date. Your AI can have the file.
PatentReply compiles the prosecution history behind US 9,067,896: the claims as filed and as allowed, every Office Action and response, and the cited references, with each answer pointing back to the filed passage.
One public application a month is free. The first compile takes a few minutes.
Strategy and filing changes require your approval.
Permanent link
www.patentreply.ai/tools/patent-expiration/US9067896Data sourced from public USPTO records. This tool provides informational estimates and should not be relied upon as legal advice. Always verify patent expiration dates independently, especially where patent term extension, terminal disclaimers, or unusual continuity issues may apply.